Fogelstrand L

The genomic landscape of relapsed infant and childhood KMT2A-rearranged acute leukemia.

Ahlgren L, Pilheden M, Sturesson H, ..., Ma J, Hagström-Andersson AK

Nat Commun 16 (1) 8964 [2025-10-08; online 2025-10-08]

Clinical Genomics [Service] Clinical Genomics Lund [Service] NGI Short read [Service] NGI Uppsala (SNP&SEQ Technology Platform) [Service] National Genomics Infrastructure [Service]

Validation of Guidelines for Genetic Investigation of Myeloid Neoplasms with Germline Predisposition: Results from a Prospective Cohort Study.

Tesi B, Robelius A, Baskin B, ..., Hellström-Lindberg E, Baliakas P

Clin. Cancer Res. 31 (14) 3062-3071 [2025-07-15; online 2025-05-19]

Clinical Genomics Lund [Service]

Ribonuclease inhibitor 1 (RNH1) deficiency cause congenital cataracts and global developmental delay with infection-induced psychomotor regression and anemia.

Hedberg-Oldfors C, Mitra S, Molinaro A, ..., Sterky FH, Darin N

Eur. J. Hum. Genet. 31 (8) 887-894 [2023-08-00; online 2023-03-20]

Clinical Genomics [Service] Clinical Genomics Gothenburg [Service]

Fusion transcript analysis reveals slower response kinetics than multiparameter flow cytometry in childhood acute myeloid leukaemia.

Karlsson L, Nyvold CG, Soboli A, ..., Abrahamsson J, Fogelstrand L

Int J Lab Hematol 44 (6) 1094-1101 [2022-12-00; online 2022-08-02]

Clinical Genomics [Service] Clinical Genomics Gothenburg [Service]

Human CD38 regulates B cell antigen receptor dynamic organization in normal and malignant B cells.

Camponeschi A, Kläsener K, Sundell T, ..., Reth M, Mårtensson IL

J. Exp. Med. 219 (9) - [2022-09-05; online 2022-07-12]

Glycoproteomics and MS Proteomics [Service]

Comparison of RNA- and DNA-based methods for measurable residual disease analysis in NPM1-mutated acute myeloid leukemia.

Pettersson L, Johansson Alm S, Almstedt A, ..., Fogelstrand L, Ehinger M

Int J Lab Hematol 43 (4) 664-674 [2021-08-00; online 2021-05-30]

Clinical Genomics [Collaborative] Clinical Genomics Gothenburg [Collaborative]